
Sign up to save your podcasts
Or


On this episode of Curbside Consults, we discuss current approaches, adverse effects, and management of complications associated with immune checkpoint inhibitors (ICIs). We are joined by Dr. Kerry Reynolds, Clinical Director of Inpatient Oncology at Massachusetts General Hospital and Director of Severe Immunotherapy Complications Service.
By NEJM Group4.7
8989 ratings
On this episode of Curbside Consults, we discuss current approaches, adverse effects, and management of complications associated with immune checkpoint inhibitors (ICIs). We are joined by Dr. Kerry Reynolds, Clinical Director of Inpatient Oncology at Massachusetts General Hospital and Director of Severe Immunotherapy Complications Service.

319 Listeners

125 Listeners

500 Listeners

57 Listeners

1,149 Listeners

5 Listeners

248 Listeners

58 Listeners

32 Listeners

49 Listeners